{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:37:51Z","timestamp":1791236271476,"version":"4.1.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anemia in children on maintenance hemodialysis (HD) leads to poor quality of life. Our study aimed to assess and monitor anemia and iron status management in children on maintenance HD over 18 months using key performance indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Key performance indicators, formulated as the percentage of patients achieving the KDIGO (2012) guideline-recommended targets for hemoglobin (Hb) (11\u201312 g\/dl), transferrin saturation (TSAT) (20\u201340%) and serum ferritin (200\u2013500 ng\/ml), were reported quarterly over the 18-month-period of this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study was carried out over an 18 month-period, from April 1st, 2020, till October 31st, 2021. A total of 78 patients (45 males and 33 females) were included; mean age 12.16\u2009\u00b1\u20093.3 years and HD duration range 3.0\u2014140.88 months, median 16.51 months. The three most common primary causes of CKD were Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) (29.5%), unknown cause (24.4%), and chronic glomerular diseases (20.5%). The quarterly reported percentages of patients achieving the recommended targets for Hb, TSAT, and serum ferritin ranges were 18.2\u201335.7%, 38.8\u201357.1%, and 11.9\u201326.6%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although the mean Hb trend was nearing the KDIGO (2012) target, the key performance indicators showed that only a small percentage of our HD patients were achieving the targets for Hb, TSAT, &amp; serum ferritin, thus alerting us to the need to revise our protocol for the management of anemia and iron status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s40620-024-02017-3","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T17:01:48Z","timestamp":1721322108000},"page":"1967-1972","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Key performance indicators for monitoring of anemia management and iron status in children attending a pediatric dialysis unit:\u00a0the experience of Ain Shams University"],"prefix":"10.1093","volume":"37","author":[{"given":"Mariam A.","family":"Khalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed F.","family":"Kasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihab Z.","family":"El-Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany M.","family":"Abd Elhafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"El Farsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragia M.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"key":"2017_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/9781119470717","volume-title":"Project management best practices: achieving global excellence","author":"H Kerzner","year":"2018","unstructured":"Kerzner H (2018) Project management best practices: achieving global excellence. Wiley, New Jersey"},{"key":"2017_CR2","volume-title":"Performance management in healthcare: from key performance indicators to balanced scorecard","author":"BP Bergeron","year":"2018","unstructured":"Bergeron BP (2018) Performance management in healthcare: from key performance indicators to balanced scorecard. Productivity Press, New York"},{"key":"2017_CR3","unstructured":"KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease (2012). Kidney International Supplements 2: 279\u2013335. https:\/\/kdigo.org\/wp-content\/uploads\/2016\/10\/KDIGO-2012-Anemia-Guideline-English.pdf"},{"key":"2017_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000496492","volume":"142","author":"A Gafter-Gvili","year":"2019","unstructured":"Gafter-Gvili A, Schechter A, Rozen-Zvi B (2019) Iron deficiency anemia in chronic kidney disease. Acta Hematol 142:44\u201350. https:\/\/doi.org\/10.1159\/000496492","journal-title":"Acta Hematol"},{"key":"2017_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s00467-002-0928-9","volume":"17","author":"AM Neu","year":"2002","unstructured":"Neu AM, Ho PL, McDonald RA, Warady BA (2002) Chronic dialysis in children and adolescents. The 2001 NAPRTCS annual report. Pediatr Nephrol 17:656\u2013663. https:\/\/doi.org\/10.1007\/s00467-002-0928-9","journal-title":"Pediatr Nephrol"},{"key":"2017_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jped.2014.05.009","volume":"91","author":"JS de Freitas","year":"2015","unstructured":"de Freitas JS, Costa PS, Costa LR, Naghettini AV (2015) Evaluation of clinical and laboratory variables associated with anemia in pediatric patients on hemodialysis. Jornal de Pediatria 91:87\u201392. https:\/\/doi.org\/10.1016\/j.jped.2014.05.009","journal-title":"Jornal de Pediatria"},{"key":"2017_CR7","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1046\/j.1523-1755.2003.00184.x","volume":"64","author":"DL Frankenfield","year":"2003","unstructured":"Frankenfield DL, Neu AM, Warady BA, Fivush BA, Johnson CA, Brem AS (2003) Anemia in pediatric hemodialysis patients: results from the 2001 ESRD clinical performance measures project. Kidney Int 64:1120\u20131124. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00184.x","journal-title":"Kidney Int"},{"key":"2017_CR8","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00467-004-1544-7","volume":"19","author":"JJ Fadrowski","year":"2004","unstructured":"Fadrowski JJ, Furth SL, Fivush BA (2004) Anemia in pediatric dialysis patients in end-stage renal disease network 5. Pediatr Nephrol 19:1029\u20131034. https:\/\/doi.org\/10.1007\/s00467-004-1544-7","journal-title":"Pediatr Nephrol"},{"key":"2017_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.31031\/ABB.2018.02.000527","volume":"2","author":"AS Abdelmageed","year":"2018","unstructured":"Abdelmageed AS, Abdelrahim M, Muddathir ERA (2018) Frequency of anemia and possible risk factors among Sudanese children with end stage renal disease. Advancements Bioequiv Availab 2:94\u201397. https:\/\/doi.org\/10.31031\/ABB.2018.02.000527","journal-title":"Advancements Bioequiv Availab"},{"key":"2017_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1053\/j.ajkd.2009.09.033","volume":"55","author":"LB Smith","year":"2010","unstructured":"Smith LB, Fadrowski JJ, Howe CJ, Fivush BA, Neu AM, Furth SL (2010) Secondary hyperparathyroidism and anemia in children treated by hemodialysis. Am J Kidney Dis 55:326\u2013334. https:\/\/doi.org\/10.1053\/j.ajkd.2009.09.033","journal-title":"Am J Kidney Dis"},{"key":"2017_CR11","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1111\/hdi.12556","volume":"21","author":"AE Gaweda","year":"2017","unstructured":"Gaweda AE (2017) Markers of iron status in chronic kidney disease. Hemodial Int 21:S21\u2013S27. https:\/\/doi.org\/10.1111\/hdi.12556","journal-title":"Hemodial Int"},{"key":"2017_CR12","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.ekir.2021.05.020","volume":"6","author":"OM Guti\u00e9rrez","year":"2021","unstructured":"Guti\u00e9rrez OM (2021) Treatment of iron deficiency anemia in CKD and end-stage kidney disease. Kidney Int Rep 6:2261\u20132269. https:\/\/doi.org\/10.1016\/j.ekir.2021.05.020","journal-title":"Kidney Int Rep"},{"key":"2017_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12882-017-0688-1","volume":"18","author":"A Mikhail","year":"2017","unstructured":"Mikhail A, Brown C, Ann Williams J, Mathrani V, Shrivastava R, Evans J, Isaac H, Bhandari S (2017) Renal association clinical practice guideline on anemia of chronic kidney disease. BMC Nephrol 18:345\u2013373","journal-title":"BMC Nephrol"},{"key":"2017_CR14","first-page":"328","volume":"8","author":"AK Mishra","year":"2013","unstructured":"Mishra AK, Tiwari A (2013) Iron overload in Beta Thalassaemia Major and Intermedia patients. Maedica 8:328\u2013332","journal-title":"Maedica"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02017-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-02017-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02017-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:37Z","timestamp":1777564417000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/7\/1967\/8306343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":14,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["2017"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-02017-3","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]},"assertion":[{"value":"28 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our study followed the tenets of the Helsinki Declarations, and was approved by the Research Ethics Committee, Faculty of Medicine, Ain Shams University (FWA 000017585; FMASU: MD 227\/2020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The present study complies with the guidelines for human studies. The study does not contain any studies with animals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from the legal guardians of all patients involved in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}